{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:31:02Z","timestamp":1768455062819,"version":"3.49.0"},"reference-count":12,"publisher":"VM Media SP. zo.o VM Group SK","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologia i Neurochirurgia Polska"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.pjnns.2017.12.012","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T03:21:01Z","timestamp":1515640861000},"page":"368-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Myasthenia Gravis-specific Activities of Daily Living scale as a useful outcome measure and in routine clinical management in Polish patients"],"prefix":"10.5603","volume":"52","author":[{"given":"Izabela Monika","family":"Rozmilowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika Helena","family":"Adamczyk-Sowa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian","family":"Czyzewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3595","reference":[{"issue":"48\u201349","key":"10.1016\/j.pjnns.2017.12.012_bib0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"issue":"116","key":"10.1016\/j.pjnns.2017.12.012_bib0070","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","author":"Conti-Fine","year":"2006","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.pjnns.2017.12.012_bib0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ane.12271","article-title":"Antititin antibody in early- and late-onset myasthenia gravis","volume":"130","author":"Szczudlik","year":"2014","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"10.1016\/j.pjnns.2017.12.012_bib0080","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.pjnns.2017.12.012_bib0085","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mus.22140","article-title":"MG-ADL: still a relevant outcome measure","volume":"44","author":"Muppidi","year":"2011","journal-title":"Muscle Nerve"},{"issue":"55","key":"10.1016\/j.pjnns.2017.12.012_bib0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pjnns.2017.12.012_bib0095","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/mus.21185","article-title":"Construction of an efficient evaluative instrument of myasthenia gravis: the MG Composite","volume":"38","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.pjnns.2017.12.012_bib0100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/mus.21053","article-title":"Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis","volume":"38","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.pjnns.2017.12.012_bib0105","doi-asserted-by":"crossref","first-page":"e0159993","DOI":"10.1371\/journal.pone.0159993","article-title":"Subcutaneous immunoglobulin therapy in the chronic management of myasthenia gravis: a retrospective cohort study","volume":"11","author":"Bourque","year":"2016","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.pjnns.2017.12.012_bib0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00415-015-7944-8","article-title":"Leflunimide treatment in corticosteroid-dependent myasthenia gravis: an open-label pilot study","volume":"263","author":"Chen","year":"2016","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.pjnns.2017.12.012_bib0115","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.intimp.2010.12.012","article-title":"Clinical efficacy and immunological impact of tacrolimus in Chinese patients with generalized myasthenia gravis","volume":"11","author":"Zhao","year":"2011","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.pjnns.2017.12.012_bib0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/WNO.0000000000000306","article-title":"Cigarette smoking and activities of daily living in ocular myasthenia gravis","volume":"36","author":"Gratton","year":"2016","journal-title":"J Neuroopthalmol"}],"container-title":["Neurologia i Neurochirurgia Polska"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028384317302207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028384317302207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T10:47:00Z","timestamp":1546944420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028384317302207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0028384317302207"],"URL":"https:\/\/doi.org\/10.1016\/j.pjnns.2017.12.012","relation":{},"ISSN":["0028-3843"],"issn-type":[{"value":"0028-3843","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Myasthenia Gravis-specific Activities of Daily Living scale as a useful outcome measure and in routine clinical management in Polish patients","name":"articletitle","label":"Article Title"},{"value":"Neurologia i Neurochirurgia Polska","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pjnns.2017.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}